These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Effects of neonatal 6-hydroxydopa treatment on monamine content of rat brain and peripheral tissues.
    Author: Kostrzewa RM.
    Journal: Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):567-79. PubMed ID: 1179028.
    Abstract:
    Treatment of rats from birth, with 6-hydroxydopa (6-OHDOPA) produced marked alterations in norepinephrine (NE) levels in the brain and spinal cord, but relatively slight changes in NE content of peripheral tissues, when rats were sacrificed at 5 weeks of age. In the neocortex, hippocampus and spinal cord 6-OHDOPA (60 mug/g i.p., 1 to 3 injections at 48 hr intervals from birth) resulted in a 20% to 85% reduction in NE. In the pons-medulla, midbrain and cerebellum, however, NE levels were elevated by 35% to 100%. Only slight alterations in NE were found in the hypothalamus, heart and spleen. Striatal levels of dopamine were unaltered by 6-OHDOPA at 5 weeks. Likewise, serotonin content of neocortex, cerebellum, pons-medulla, midbrain and hypothalamus was unchanged at 5 weeks, although slight elevations were seen in the neocortex and cerebellum at 2 weeks. The above effects indicate that neonatal 6-OHDOPA produces a relatively selective long term alteration of central stores of NE in the rat.
    [Abstract] [Full Text] [Related] [New Search]